Overview

Pharmacokinetic Study With Colchicine in Healthy Volunteers

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This open label, single group, sequential dose study will compare the single dose pharmacokinetics of colchicine 0.6 mg given orally to colchicine pharmacokinetics after 10 days of a standard prophylactic dose (0.6 mg every 12 hours) in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Mutual Pharmaceutical Company, Inc.
Treatments:
Colchicine